Skip to main content
. Author manuscript; available in PMC: 2019 Oct 18.
Published in final edited form as: Cell. 2018 Oct 18;175(3):615–632. doi: 10.1016/j.cell.2018.09.010

Figure 3: Comparison of in vitro and chimeric in vivo approaches to model complex disease-associated phenotypes.

Figure 3:

hPSCs, human pluripotent stem cells; NPs, neural progenitors; TF, transcription factor.